R&D dominates Indo-Aus collaborations
Australia | Analysis | By Rahul Koul Koul | 0 Comment | 18 May, 2012
There has been a significant increase in industry-to-academia and industry-to-industry interactions between Indian and A...Read more
Alchemia cancer drug gets US patent protection
Australia | News | By BioSpectrum Bureau | 0 Comment | 04 Apr, 2013
Singapore: Alchemia has been granted a further patent term adjustment for a key HyACT US patent, as well as an important...Read more
bioCSL inks a deal with Immucor
Australia | News | By BioSpectrum Bureau | 0 Comment | 21 Jul, 2014
Singapore: BioCSL has inked a deal with US-based Immucor to distribute transfusion testing technology in Australia and N...Read more
Phosphagenics +ve on new pain tech
Australia | News | By BioSpectrum Bureau | 0 Comment | 21 Feb, 2013
Singapore: Melbourne-based Phosphagenics completed a pre-clinical study demonstrating that its oxycodone/TPM technology ...Read more
Helmedix to work on novel autoimmune therapy
Australia | News | By BioSpectrum Bureau | 0 Comment | 14 Feb, 2013
Singapore: Helmedix, an early stage biopharma company developing novel therapies for autoimmune and inflammatory diseas...Read more
Prana Biotech readies to progress PBT2 to market
Australia | News | By BioSpectrum Bureau | 0 Comment | 02 Aug, 2013
Singapore: Australia-based Prana Biotechnology is to make senior appointments as it prepares to advance its key drug to ...Read more
Aus science academy seeks award applications
Australia | News | By BioSpectrum Bureau | 0 Comment | 18 Feb, 2013
Singapore: The Australian Academy of Science has opened applications for its 2014 round of prestigious awards, including...Read more
Ansell launches GAMMEX non-latex surgical glove
Australia | News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2012
Singapore: Australia-based Ansell, a global leader in protection solutions, has introduced a ground-breaking new Sensopr...Read more
Consumers are winners in the BRCA gene case
Australia | News | By BioSpectrum Bureau | 0 Comment | 09 Jul, 2013
In the wake of US Supreme Court's win-win verdict in Association for Molecular Pathology vs Myriad Genetics case, Frost ...Read more
Australia | Company results | By BioSpectrum Bureau | 0 Comment | 15 Aug, 2013
Singapore: Australian biopharmaceutical giant CSL has marked sales of $5 billion, achieving a net profit after tax (NPAT...Read more
BioDiem to create new non-influenza vaccines
Australia | News | By BioSpectrum Bureau | 0 Comment | 20 Jul, 2012
Singapore: Australian infectious disease therapy and vaccine development company BioDiem has signed an agreement with Th...Read more
Allied to soon get CE mark approval from EU
Australia | News | By BioSpectrum Bureau | 0 Comment | 15 Feb, 2013
Singapore: Australia's Allied Healthcare is progressing in the regulatory process for obtaining European CE Mark approva...Read more
Researchers create biologically active antibodies
Australia | News | By BioSpectrum Bureau | 0 Comment | 29 Jun, 2012
Singapore: Australian scientists have overcome one of the most pressing problems facing the pharmaceutical industry, how...Read more
Mesoblast CEO: We have $178 mn cash reserves
Australia | Influencers | By Rahul Koul Koul | 4 Comment | 07 Feb, 2013
Australia-based Mesoblast is one-of-the-world's leading developer of innovative biological products in regenerative medi...Read more
Toshiba to distribute Nanosonics trophon EPR in UK
Australia | News | By BioSpectrum Bureau | 0 Comment | 17 Apr, 2013
Singapore: Australia's Nanosonics has signed an agreement with Toshiba Medical Systems and has made Toshiba a non-exclus...Read more
Roche Accu-Chek Combo gets FDA approval
Australia | Regulatory | By BioSpectrum Bureau | 0 Comment | 19 Jul, 2012
Singapore: Roche received clearance from the US FDA for its Accu-Chek Combo system for insulin pump therapy. The system ...Read more
Australia pumps in $32.8 mn for diabetes research
Australia | News | By BioSpectrum Bureau | 0 Comment | 11 Jul, 2014
Singapore: The Australian Minister for Education, Mr Christopher Pyne, and Minister for Health, Mr Peter Dutton have ann...Read more
Phosphagenics: Our ex-CEO Esra Ogru stole $5.7 mn
Australia | News | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2013
Singapore: Phosphagenics has charged Dr Esra Ogru, its former CEO, of being implicated in the theft of $5.7 million from...Read more